Free Trial
OTCMKTS:BRTXQ

BioRestorative Therapies (BRTXQ) Stock Price, News & Analysis

$1.65
-0.02 (-1.20%)
(As of 07/19/2024 ET)
Today's Range
$1.61
$1.69
50-Day Range
$1.16
$2.22
52-Week Range
$0.00
$0.06
Volume
27,532 shs
Average Volume
62.17 million shs
Market Capitalization
$2.71 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BRTXQ stock logo

About BioRestorative Therapies Stock (OTCMKTS:BRTXQ)

BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. The BRTX-100 utilizes proprietary technology and involves collecting a patient's bone marrow, isolating and culturing stem cells from the bone marrow, and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient's damaged disc and treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. The company have received authorization from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100to treat persistent lower back pain due to painful degenerative discs. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy in preclinical stage to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). In addition, the company provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and a research agreement with Pfizer, Inc. and the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. On March 20, 2020, BioRestorative Therapies, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of New York.

BRTXQ Stock Price History

BRTXQ Stock News Headlines

[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Why BioRestorative Therapies Is Rising In Pre-market?
[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
BioRestorative Therapies Inc BRTX
Occupational Therapy Assistant Salary
See More Headlines
Receive BRTXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioRestorative Therapies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous Health & Allied Services
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:BRTXQ
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$110,000.00
Price / Sales
24,594.39
Book Value
($0.68) per share

Miscellaneous

Outstanding Shares
1,639,626,000
Free Float
N/A
Market Cap
$2.71 billion
Optionable
Not Optionable
Beta
102.36
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Mark R. Weinreb M.S. (Age 67)
    Chairman, CEO & Pres
    Comp: $407.2k
  • Mr. Robert Paccasassi (Age 51)
    VP of Quality & Compliance
    Comp: $233.95k
  • Mr. Francisco J. Silva (Age 45)
    Chief Scientist and VP of R&D
    Comp: $310.5k
  • Dr. Wayne J. Olan
    Clinical Director of Regenerative Disc & Spine Program and Member of Scientific Advisory Board

BRTXQ Stock Analysis - Frequently Asked Questions

How have BRTXQ shares performed this year?

BioRestorative Therapies' stock was trading at $1.7399 at the start of the year. Since then, BRTXQ shares have decreased by 5.2% and is now trading at $1.65.
View the best growth stocks for 2024 here
.

How do I buy shares of BioRestorative Therapies?

Shares of BRTXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BRTXQ) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners